Page 104 - FINAL PROGRAMME 2017

10:30 O-118
Randomized clinical trial to compare the pregnancy rates of vaginally applied progesterone 400 mg pessary and progesterone 8% gel after in-vitro fertilization
J. Urbancsek1, G. Stamenov2, B. Kuřecová3, A. Ljubic4, T.B. Magnusdottir5, S. Hrafnsdottir5, M. Wargenau6, I. Klingmann7, T. D'Hooghe8,9
1Semmelweis University, 1st Dept. of Ob/Gyn, Budapest, Hungary
2Nadejda Reproductive So a Medical Center, Assisted Reproduction, So a, Bulgaria
3Repro t International, N/A, Brno, Czech Republic
4Special Gynecological Hospital "Jevremova", N/A, Belgrade, Serbia
5Actavis Group PTC ehf.- now part of Teva Pharmaceuticals, Clinical Research and Development, Hafnarfjordur 220, Iceland
6M.A.R.C.O. GmbH & Co. KG, N/A, Düsseldorf, Germany
7Pharmaplex bvba, N/A, Wezembeek-Oppem, Belgium
8KU Leuven, Faculty of Medicine and University Fertility Center, Leuven, Belgium 9Merck KGaA since October 2015, Global Medical Affairs- Fertility, Darmstadt, Germany
Combination tocolytics on the inhibition of OT-induced contractions of human pregnant myometrium in vitro
L. Riaposova1, S.H. Kim1, O. Pohl2, A. Chollet2, J.P. Gotteland2, A. Hanyaloglu3, P. Bennett1, V. Terzidou1
1Imperial College London, Surgery and Cancer - Parturition Research Group, London, United Kingdom
2ObsEva SA, Chemin des Aulx 12- CH-1228 Plan-les-Ouates, Geneva, Switzerland
3Imperial College London, Surgery and Cancer - GPCR Research Group, London, United Kingdom
Melatonin in assisted reproductive technology: the MIART trial - a pilot double-blind randomised placebo-controlled clinical trial
S. Fernando1,2, E. Wallace3,4, L. Rombauts3,5
1The Ritchie Centre, Obstetrics and Gynecology, Clayton, Australia
2Hudson Instituite of Medical Research, Obstetrics and Gynaecology, Clayton, Australia 3The Ritchie Centre, Obstetrics and Gynaecology, Clayton, Australia
4Hudson Institute of Medical Research, Obstetrics and Gynaecology, Clayton, Australia 5Monash IVF, Monash IVF, Clayton, Australia
Testosterone treatment in women with poor ovarian repsonse: fertility and live birth rates
G. Mskhalaya1, E. Eltsova2, M. Malysheva3, V. Zaletova4, S. Kalinchenko5, Y. Tishova6
1Center for Reproductive Medicine MAMA, Moscow, Russia C.I.S.
2Center for Reproductive Medicine MAMA, Andrology and Endocrinology, Moscow, Russia C.I.S. 3Center for Reproductive Medicine MAMA, Gynecology, Moscow, Russia C.I.S.
4Center for Reproductive Medicine MAM, Gynecology, Moscow, Russia C.I.S.
5People's Friendship University of Russia, Endocinology, Moscow, Russia C.I.S.
6People's Friendship University of Russia, Endocrinology, Moscow, Russia C.I.S.
10:45 O-119
11:00 O-120
11:15 O-121
104